NMIN

RMC Advisory committees

In addition to the advisory committees below (the HQP Program Advisory Committee and the Commercialization Advisory Board), the RMC also receives input from the Executive Committee of the NMIN HQP Network (NHN).

HQP Program Advisory Committee

The HQP Program Advisory Committee (HPAC) is an advisory standing committee reporting to the Research Management Committee (RMC) of NMIN. The HPAC has up to 10 members.

The mandate of the HPAC is to advise RMC on training and programming opportunities that will increase the knowledge, skills and expertise of trainees and new professionals in the field of nanomedicine.

CHAIR: Nicolas Bertrand

Associate Professor, Université Laval

Ildiko Badea

Professor, College of Pharmacy and Nutrition University of Saskatchewan

Devika Chithrani

Associate Professor, Department of Physics & Astronomy, University of Victoria

Michael Doschak

Professor, Pharmacy & Pharmaceutical Sciences, University of Alberta

Marianna Foldvari

Professor of Pharmaceutical Sciences, University of Waterloo

Emmanuel Ho

Associate Professor, School of Pharmacy & Dept. of Chemical Engineering, University of Waterloo

Andrew R. Martin

Associate Professor, Mechanical Engineering, University of Alberta

Naomi Matsuura

Associate Professor, Materials Science & Engineering, University of Toronto

Donald Miller

Professor, Department of Pharmacology & Therapeutics, University of Manitoba

Commercialization Advisory Board

The Commercialization Advisory Board (CAB) provides arm’s-length, expert review and assessment of the funding eligibility of applications to NMIN’s Strategic Initiative (SI) KTEE/Commercialization Support program.

It also provides advice and mentorship to NMIN investigators seeking to commercialize their network-supported intellectual property (NSIP).

CHAIR: Brenna Rauw

Founder and Managing Director, 12Bridge

Stephen Dibert

Strategic Advisor – Life Sciences, Medtech Canada; CEO, TOHealt

Inès Holzbaur

Co-Founder & Managing Partner, AmorChem

Wendy Lamson

Partner and Patent Agent, Perley-Robertson, Hill & McDougall

Linh Le

Founder and CEO, Flextrapower Technologies

Helen Loughrey

Health Challenge Officer, National Research Council Canada

Paul Santerre

Professor & Baxter Chair in Health Technology & Commercialization (UHN), University of Toronto

Andrew Sinclair

Technology Executive

Gary Skarja

Head of Membrane Chromatography R&D, MilliporeSigma

Helen Loughrey

Health Challenge Officer, National Research Council Canada

Paul Santerre

Professor & Baxter Chair in Health Technology & Commercialization (UHN), University of Toronto

Andrew Sinclair

Technology Executive